Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,122,625
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
3,077,170
-
Shares change
-
-458,951
-
Total reported value, excl. options
-
$36,007,642
-
Value change
-
-$8,143,138
-
Number of buys
-
16
-
Number of sells
-
-16
-
Price
-
$11.70
Significant Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q1 2021
45 filings reported holding LUMO - LUMOS PHARMA INC - Common Stock as of Q1 2021.
LUMOS PHARMA INC - Common Stock (LUMO) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3,077,170 shares
of 8,122,625 outstanding shares and own 38% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (526,663 shares), Blackstone Group Inc. (468,145 shares), Lion Point Capital, LP (407,192 shares), Opaleye Management Inc. (376,900 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (373,117 shares), RENAISSANCE TECHNOLOGIES LLC (332,419 shares), WELLS FARGO & COMPANY/MN (166,066 shares), Jefferies Group LLC (120,651 shares), BlackRock Inc. (71,078 shares), and BRIDGEWAY CAPITAL MANAGEMENT, LLC (52,543 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.